143 related articles for article (PubMed ID: 219024)
1. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
Champney KJ; Lauter CB; Bailey EJ; Lerner AM
J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1.
Williams BB; Bailey EJ; Lerner AM
J Lab Clin Med; 1977 Apr; 89(4):687-91. PubMed ID: 191546
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor.
Falcon MG; Jones BR
J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of varicella zoster virus to adenine arabinoside and hypoxanthine arabinoside.
Bryson YJ; Connor JD
Antimicrob Agents Chemother; 1976 Mar; 9(3):540-3. PubMed ID: 176937
[TBL] [Abstract][Full Text] [Related]
5. Anti-herpes activity of adenine arabinoside monophosphate.
Trobe JD; Centifanto Y; Zam ZS; Varnell E; Kaufman HE
Invest Ophthalmol; 1976 Mar; 15(3):196-9. PubMed ID: 1254407
[TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine.
Lerner AM; Bailey EJ
J Infect Dis; 1976 Oct; 134(4):400-4. PubMed ID: 185303
[TBL] [Abstract][Full Text] [Related]
7. Antiviral chemotherapy and neonatal herpes simplex virus infecition: a pilot study--experience with adenine arabinoside (ARA-A).
Ch'ien LT; Whitley RJ; Nahmias AJ; Lewin EB; Linnemann CC; Frenkel LD; Bellanti JA; Buchanan RA; Alford DA
Pediatrics; 1975 May; 55(5):678-85. PubMed ID: 165453
[TBL] [Abstract][Full Text] [Related]
8. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in synchronized suspension cultures.
Shipman C; Smith SH; Carlson RH; Drach JC
Antimicrob Agents Chemother; 1976 Jan; 9(1):120-7. PubMed ID: 176927
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor.
Schwartz PM; Shipman C; Drach JC
Antimicrob Agents Chemother; 1976 Jul; 10(1):64-74. PubMed ID: 185947
[TBL] [Abstract][Full Text] [Related]
10. Microbiologic assays and neurological toxicity during use of adenine arabinoside in humans.
Lauter CB; Bailey EJ; Lerner AM
J Infect Dis; 1976 Jul; 134(1):75-9. PubMed ID: 181499
[TBL] [Abstract][Full Text] [Related]
11. Effect of ara-T on the replication of herpes simplex virus, varicella-zoster virus and cytomegalovirus.
Miller RL; Iltis JP; Rapp F
IARC Sci Publ (1971); 1978; (24 Pt 2):991-7. PubMed ID: 221418
[TBL] [Abstract][Full Text] [Related]
12. [Combined action of nucleosides and alpha-interferon in inhibiting the reproduction of the herpes simplex type-II virus].
Temicheva EV; Malinovskaia VV; Manakhova LS; Mironova LL; Galegov GA
Biull Eksp Biol Med; 1987 Oct; 104(10):490-2. PubMed ID: 2823929
[TBL] [Abstract][Full Text] [Related]
13. Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine.
Smith SH; Shipman C; Drach JC
Cancer Res; 1978 Jul; 38(7):1916-21. PubMed ID: 207416
[TBL] [Abstract][Full Text] [Related]
14. Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus.
Williams BB; Lerner AM
J Infect Dis; 1975 Jun; 131(6):673-7. PubMed ID: 166117
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antiherpes virus activity of acyclovir and interferon in human corneal stromal cells.
Taylor JL; Casey MS; O'Brien WJ
Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):365-70. PubMed ID: 2466806
[TBL] [Abstract][Full Text] [Related]
16. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
17. Metabolism and pharmacokinetics of the anti-varicella-zoster virus agent 6-dimethylaminopurine arabinoside.
Lambe CU; Resetar A; Spector T; Koszalka GW; Nelson DJ
Antimicrob Agents Chemother; 1992 Feb; 36(2):353-60. PubMed ID: 1318679
[TBL] [Abstract][Full Text] [Related]
18. [The synergistic antiviral effect of acyclovir and ribavirin against the herpes simplex type-1 virus and the pseudorabies virus in vitro].
Shishkov S; Pancheva S
Acta Microbiol Bulg; 1990; 25():69-75. PubMed ID: 2166426
[TBL] [Abstract][Full Text] [Related]
19. Adenine arabinoside (ARA-A) blocked HSV-2 infected human skin fibroblasts as targets for the detection of serum mediated and cellular cytotoxicity in patients with cervical carcinoma.
Paulileinikki ES; Vesterinen E
Clin Exp Immunol; 1976 Aug; 25(2):264-9. PubMed ID: 182421
[TBL] [Abstract][Full Text] [Related]
20. Effects on herpes simplex virus type 1 of combined use of interferon-beta and anti-herpetic agents in vitro.
Naito T; Shiota H; Nitta K; Mimura Y
Jpn J Ophthalmol; 1990; 34(1):15-21. PubMed ID: 2163462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
